These assays indicated that moderate and severe COVID-19 patients produced detectable levels of S-specific IgM, IgG and IgA antibodies, suggesting that SARS-CoV-2 infection triggers universal production of antibody isotypes against the virus. The gene discussed is CD79A; the disease is COVID-19.